Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
This study examines the effect of standardized protocol in reducing complications for patients with cardiovascular disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
180
Patients in the control group will receive the usual practice of subcutaneous LMWH injection administered by nurses.
Nurses administer LMWH according to the standardized evidence-based protocol.
Hospital Authority, Hong Kong
Hong Kong, Hong Kong
RECRUITINGBruise size
The bruising length and width will be measured by a ruler and the incidence of bruising will be recorded.
Time frame: 24 hours, 48 hours, 72 hours
Pain level
Patients' pain levels are assessed using the Numeric Rating Scale: from o to 10, with "10" representatin the worst outcome and with '0' representing the best outcome.
Time frame: Immediately after injection, 24 hours, 48 hours, 72 hours
Patient Experience
a Patient Experience Surveys to evaluate their perceived nurse's attitude
Time frame: Immediately after receiving the injection
Communicative Competence
Communicative Competence Scale consists of 36 items across five dimensions (General Competence, Empathy Affiliation/Support, Behavioural Flexibility, and Social Relaxation), using a 5-point Likert scales ranging from strongly agree to strongly disagree (coded from 1 to 5). Higher the score means worse the outcome.
Time frame: Immediately before and after injection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.